After a month gap in choosing the new CEO after Michel Vounatsos, Biogen has finally named Christopher Viehbacher as its new CEO.

Clinical trials on 1800 patients with early-stage Alzheimer's has showed that Lecanemab slows the advance of the disease.

Eisai Co, a Tokyo-based pharmaceutical company with a family bent and market capitalisation of $14 billion, crossed the finish line before ...

Dr Reddy's will receive $ 40 million upfront upon the closing of the transaction, followed by approval milestone payment of up to $40 milli...

The Nikkei share average ended 0.35 per cent lower at 28,860.80, while the broader Topix was down 0.28 per cent at 1,957.14.

Nikkei inched down 0.2 per cent to close at 28,963.56, while the Topix edged up 0.1 per cent at 1,962.65.

The Nikkei index settled 1.59% higher at 22,945.50 after hitting its highest level since June 10, with industrial and consumer discretional...

Sony Corp added 3.27%, while Yaskawa Electric Corp rose 1.98%.

The Nikkei share average rose 1.52 per cent to 19,429.44 after three straight sessions of losses.

Chip equipment makers jumped, tracking a rise in US tech shares overnight.

The weaker yen triggered futures buying in late trade.

Other drug companies whose acquisition went southwards included Mitsui & Co, which acquired a significant stake in Arch Pharma.

Dr Reddy's Laboratories today said it has launched generic Donepezil Hydrochloride tablets, used to treat Alzheimer's disease, in the US ma...

Ranbaxy Laboratories on Tuesday said it has received approval from the US health regulator to sell generic Alzheimer's disease drug donepez...

Pharma companies in Andhra Pradesh say they are losing heavily due to the Telengana unrest in the State.

Ranbaxy Laboratories has received tentative approval from the US Food and Drug Administration (USFDA) to manufacture and market donepezil h...

Japanese drug major Eisai Company, which has a marginal presence in India with just two products, will soon invest Rs 180 crore to start ma...